Hashim Zaibak, PharmD, joined Over the Counter to discuss the overall role of pharmacists in administering vaccines and how community pharmacies in particular have stepped up in a big way.

Michael Murphy, PharmD, MBA, joined Over the Counter to discuss the growing concerns surrounding pharmacy deserts that are spanning across thousands of communities in the US.

Michael Kleinrock, lead research director at IQVIA, joined Over the Counter to discuss the importance of his company's Understanding the Use of Medicines in the US 2025 report.

Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES, joined Over the Counter to discuss the importance of insulin delivery and how advancements in this space are expected to improve diabetes outcomes.

Brett Barker, PharmD, joined Over the Counter to discuss Iowa's recent signing of PBM reform and what it might mean for pharmacies and other states looking to enact similar legislation.

Jon Easter, RPh, joined Over the Counter to discuss the main ideas of his presentation from the American Diabetes Association's 85th Scientific Sessions.

Rick Gates, chief pharmacy officer at Walgreens, joined Over the Counter to discuss the current state of retail pharmacy and the ongoing events that have impacted it.

Morgan Lee, PhD, MPH, CPH, and Scott Halperin, PharmD, from the Pharmaceutical Strategies Group, joined Over the Counter to discuss key takeaways in their organization's 2025 Trends in Drug Benefit Design Report.

Amina Abubakar, PharmD, AAHIVP, joined Over the Counter to discuss her career journey within the pharmacy profession, from her time in big-box retail to owning an independent pharmacy and continuing education institute.

Marta Wosinska, PhD, and Joey Mattingly, PharmD, MBA, PhD, joined Over the Counter to discuss the potential impact pharmaceutical tariffs may have on pharmacies if they are to be widely implemented in the near future.